Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers

Cynthia Gordon, Kirana Gudi, Anja Krause, Rachel Sackrowitz, Ben Gary Harvey, Yael Strulovici-Barel, Jason G. Mezey, Ronald Crystal

Research output: Contribution to journalArticle

122 Citations (Scopus)

Abstract

Rationale: There is increasing evidence thatemphysemais associated with primary loss of pulmonary capillary endothelium. Plasma levels of endothelial microparticles (EMPs), small vesicles released from activated or apoptotic endothelial cells, are elevated in vascularrelated disorders. Objectives: To evaluate whether plasma EMP levels are elevated in smokers with early lung destruction as assessed by normal spirometry but reduced diffusing capacity of the lung for carbon monoxide (DLCO). Methods: Lung health was assessed by pulmonary function tests (PFTs: spirometry, total lung capacity, DLCO) and chest X-ray; smoking status was assessed by urine nicotine and cotinine. EMP levels (CD42b-CD31+ microparticles) were quantified as activated or apoptotic. The initial cohort (n = 92) included healthy nonsmokers (normal PFTs), healthy smokers (normal PFTs), and smokers with early evidence of lung destruction (normal spirometry, low DLCO). Two prospective cohorts were then tested: a group similar to the initial cohort and an HIV1+ cohort. Measurements and Main Results: Healthy smokers had mildly increased levels of EMPs. Strikingly, 95% of smokers with normal spirometry, low DLCO had increased EMPs, with reduced CD62+/CD31+ ratios (P < 10-4) and elevated CD42b-CD31+ annexin V+ EMPs (P <10-4), suggesting derivation from endothelial apoptosis. Most elevated EMPs were angiotensin-converting enzyme positive, suggesting derivation from pulmonary capillaries. Both prospective cohorts confirmed the initial cohort data. Conclusions: Plasma EMPs with apoptotic characteristics are elevated in smokers with normal spirometry but reduced DLCO, consistent with the concept that emphysema is associated, in part, with capillary endothelium apoptosis, suggesting that the early development of emphysema might be monitored with plasma EMP levels.

Original languageEnglish
Pages (from-to)224-232
Number of pages9
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume184
Issue number2
DOIs
Publication statusPublished - 15 Jul 2011
Externally publishedYes

Fingerprint

Spirometry
Tobacco Products
Lung
Emphysema
Vascular Endothelium
Apoptosis
Lung Volume Measurements
Total Lung Capacity
Cotinine
Annexin A5
Respiratory Function Tests
Peptidyl-Dipeptidase A
Carbon Monoxide
Nicotine
Thorax
Endothelial Cells
Smoking
X-Rays
Urine
Health

Keywords

  • Apoptosis
  • Endothelium
  • Endothelium-derived factors
  • Microcirculation
  • Smoking

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers. / Gordon, Cynthia; Gudi, Kirana; Krause, Anja; Sackrowitz, Rachel; Harvey, Ben Gary; Strulovici-Barel, Yael; Mezey, Jason G.; Crystal, Ronald.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 184, No. 2, 15.07.2011, p. 224-232.

Research output: Contribution to journalArticle

Gordon, Cynthia ; Gudi, Kirana ; Krause, Anja ; Sackrowitz, Rachel ; Harvey, Ben Gary ; Strulovici-Barel, Yael ; Mezey, Jason G. ; Crystal, Ronald. / Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers. In: American Journal of Respiratory and Critical Care Medicine. 2011 ; Vol. 184, No. 2. pp. 224-232.
@article{f1e86b7d5c7f4f5bb0bb37deb52b8038,
title = "Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers",
abstract = "Rationale: There is increasing evidence thatemphysemais associated with primary loss of pulmonary capillary endothelium. Plasma levels of endothelial microparticles (EMPs), small vesicles released from activated or apoptotic endothelial cells, are elevated in vascularrelated disorders. Objectives: To evaluate whether plasma EMP levels are elevated in smokers with early lung destruction as assessed by normal spirometry but reduced diffusing capacity of the lung for carbon monoxide (DLCO). Methods: Lung health was assessed by pulmonary function tests (PFTs: spirometry, total lung capacity, DLCO) and chest X-ray; smoking status was assessed by urine nicotine and cotinine. EMP levels (CD42b-CD31+ microparticles) were quantified as activated or apoptotic. The initial cohort (n = 92) included healthy nonsmokers (normal PFTs), healthy smokers (normal PFTs), and smokers with early evidence of lung destruction (normal spirometry, low DLCO). Two prospective cohorts were then tested: a group similar to the initial cohort and an HIV1+ cohort. Measurements and Main Results: Healthy smokers had mildly increased levels of EMPs. Strikingly, 95{\%} of smokers with normal spirometry, low DLCO had increased EMPs, with reduced CD62+/CD31+ ratios (P < 10-4) and elevated CD42b-CD31+ annexin V+ EMPs (P <10-4), suggesting derivation from endothelial apoptosis. Most elevated EMPs were angiotensin-converting enzyme positive, suggesting derivation from pulmonary capillaries. Both prospective cohorts confirmed the initial cohort data. Conclusions: Plasma EMPs with apoptotic characteristics are elevated in smokers with normal spirometry but reduced DLCO, consistent with the concept that emphysema is associated, in part, with capillary endothelium apoptosis, suggesting that the early development of emphysema might be monitored with plasma EMP levels.",
keywords = "Apoptosis, Endothelium, Endothelium-derived factors, Microcirculation, Smoking",
author = "Cynthia Gordon and Kirana Gudi and Anja Krause and Rachel Sackrowitz and Harvey, {Ben Gary} and Yael Strulovici-Barel and Mezey, {Jason G.} and Ronald Crystal",
year = "2011",
month = "7",
day = "15",
doi = "10.1164/rccm.201012-2061OC",
language = "English",
volume = "184",
pages = "224--232",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "2",

}

TY - JOUR

T1 - Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers

AU - Gordon, Cynthia

AU - Gudi, Kirana

AU - Krause, Anja

AU - Sackrowitz, Rachel

AU - Harvey, Ben Gary

AU - Strulovici-Barel, Yael

AU - Mezey, Jason G.

AU - Crystal, Ronald

PY - 2011/7/15

Y1 - 2011/7/15

N2 - Rationale: There is increasing evidence thatemphysemais associated with primary loss of pulmonary capillary endothelium. Plasma levels of endothelial microparticles (EMPs), small vesicles released from activated or apoptotic endothelial cells, are elevated in vascularrelated disorders. Objectives: To evaluate whether plasma EMP levels are elevated in smokers with early lung destruction as assessed by normal spirometry but reduced diffusing capacity of the lung for carbon monoxide (DLCO). Methods: Lung health was assessed by pulmonary function tests (PFTs: spirometry, total lung capacity, DLCO) and chest X-ray; smoking status was assessed by urine nicotine and cotinine. EMP levels (CD42b-CD31+ microparticles) were quantified as activated or apoptotic. The initial cohort (n = 92) included healthy nonsmokers (normal PFTs), healthy smokers (normal PFTs), and smokers with early evidence of lung destruction (normal spirometry, low DLCO). Two prospective cohorts were then tested: a group similar to the initial cohort and an HIV1+ cohort. Measurements and Main Results: Healthy smokers had mildly increased levels of EMPs. Strikingly, 95% of smokers with normal spirometry, low DLCO had increased EMPs, with reduced CD62+/CD31+ ratios (P < 10-4) and elevated CD42b-CD31+ annexin V+ EMPs (P <10-4), suggesting derivation from endothelial apoptosis. Most elevated EMPs were angiotensin-converting enzyme positive, suggesting derivation from pulmonary capillaries. Both prospective cohorts confirmed the initial cohort data. Conclusions: Plasma EMPs with apoptotic characteristics are elevated in smokers with normal spirometry but reduced DLCO, consistent with the concept that emphysema is associated, in part, with capillary endothelium apoptosis, suggesting that the early development of emphysema might be monitored with plasma EMP levels.

AB - Rationale: There is increasing evidence thatemphysemais associated with primary loss of pulmonary capillary endothelium. Plasma levels of endothelial microparticles (EMPs), small vesicles released from activated or apoptotic endothelial cells, are elevated in vascularrelated disorders. Objectives: To evaluate whether plasma EMP levels are elevated in smokers with early lung destruction as assessed by normal spirometry but reduced diffusing capacity of the lung for carbon monoxide (DLCO). Methods: Lung health was assessed by pulmonary function tests (PFTs: spirometry, total lung capacity, DLCO) and chest X-ray; smoking status was assessed by urine nicotine and cotinine. EMP levels (CD42b-CD31+ microparticles) were quantified as activated or apoptotic. The initial cohort (n = 92) included healthy nonsmokers (normal PFTs), healthy smokers (normal PFTs), and smokers with early evidence of lung destruction (normal spirometry, low DLCO). Two prospective cohorts were then tested: a group similar to the initial cohort and an HIV1+ cohort. Measurements and Main Results: Healthy smokers had mildly increased levels of EMPs. Strikingly, 95% of smokers with normal spirometry, low DLCO had increased EMPs, with reduced CD62+/CD31+ ratios (P < 10-4) and elevated CD42b-CD31+ annexin V+ EMPs (P <10-4), suggesting derivation from endothelial apoptosis. Most elevated EMPs were angiotensin-converting enzyme positive, suggesting derivation from pulmonary capillaries. Both prospective cohorts confirmed the initial cohort data. Conclusions: Plasma EMPs with apoptotic characteristics are elevated in smokers with normal spirometry but reduced DLCO, consistent with the concept that emphysema is associated, in part, with capillary endothelium apoptosis, suggesting that the early development of emphysema might be monitored with plasma EMP levels.

KW - Apoptosis

KW - Endothelium

KW - Endothelium-derived factors

KW - Microcirculation

KW - Smoking

UR - http://www.scopus.com/inward/record.url?scp=80051565223&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051565223&partnerID=8YFLogxK

U2 - 10.1164/rccm.201012-2061OC

DO - 10.1164/rccm.201012-2061OC

M3 - Article

VL - 184

SP - 224

EP - 232

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 2

ER -